The DOI matches its Crossref record; 244 of the 244 references it cites were found in a registry or an index.
MicroRNA delivery through nanoparticles
Open accessAbstract
MicroRNAs (miRNAs) are attracting a growing interest in the scientific community due to their central role in the etiology of major diseases. On the other hand, nanoparticle carriers offer unprecedented opportunities for cell specific controlled delivery of miRNAs for therapeutic purposes. This review critically discusses the use of nanoparticles for the delivery of miRNA-based therapeutics in the treatment of cancer and neurodegenerative disorders and for tissue regeneration. A fresh perspective is presented on the design and characterization of nanocarriers to accelerate translation from basic research to clinical application of miRNA-nanoparticles. Main challenges in the engineering of miRNA-loaded nanoparticles are discussed, and key application examples are highlighted to underline their therapeutic potential for effective and personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Xu, C., Lu, Y., Pan, Z., Chu, W., Luo, X., Lin, H., Xiao, J., Shan, H., Wang, Z., & Yang, B. (2007) · Journal of Cell Science · doi:10.1242/jcs.010728 · Cited by 439
RetractedZhang, X., He, X., Liu, Y., Zhang, H., Chen, H., Guo, S., & Liang, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.005 · Cited by 97
RetractedThe C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · cited 1×
“To overcome these barriers, miRNA-loaded nanoparticles (NPs) have been proposed [21–23], by virtue of NPs ability to shield the loaded agent from the external environment, thereby reducing inactivation or degradation, and enhancing circulation time and targeted accumulation [24].”
BackgroundUnderstanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Jain, P. K., Lee, K. S., El-Sayed, I. H., & El-Sayed, M. A. (2006) · The Journal of Physical Chemistry B · doi:10.1021/jp057170o · Cited by 4,603
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592
Asymmetry in the Assembly of the RNAi Enzyme Complex
Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922
Processing of primary microRNAs by the Microprocessor complex
Denli, A. M., Tops, B. B. J., Plasterk, R. H. A., Ketting, R. F., & Hannon, G. J. (2004) · Nature · doi:10.1038/nature03049 · Cited by 2,784
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
Agnihotri, S. A., Mallikarjuna, N. N., & Aminabhavi, T. M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.010 · Cited by 2,586
MicroRNA maturation: stepwise processing and subcellular localization
Lee, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf476 · Cited by 2,478
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity
Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J., & Wyatt, M. D. (2005) · Small · doi:10.1002/smll.200400093 · Cited by 2,406
Toxicity of cationic lipids and cationic polymers in gene delivery
Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286
Control of translation and mRNA degradation by miRNAs and siRNAs: Table 1.
Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., & Parker, R. (2006) · Genes & Development · doi:10.1101/gad.1399806 · Cited by 2,060
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Polymer nanoparticles: Preparation techniques and size-control parameters
Rao, J. P., & Geckeler, K. E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.01.001 · Cited by 1,725
MicroRNA-Directed Cleavage of HOXB8 mRNA
Yekta, S., Shih, I.-H., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1097434 · Cited by 1,702
A microRNA in a Multiple-Turnover RNAi Enzyme Complex
Hutvágner, G., & Zamore, P. D. (2002) · Science · doi:10.1126/science.1073827 · Cited by 1,674
Specificity of microRNA target selection in translational repression
Doench, J. G., & Sharp, P. A. (2004) · Genes & Development · doi:10.1101/gad.1184404 · Cited by 1,636
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
van Rooij, E., Sutherland, L. B., Liu, N., Williams, A. H., McAnally, J., Gerard, R. D., Richardson, J. A., & Olson, E. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608791103 · Cited by 1,507
Cancer immunotherapy: harnessing the immune system to battle cancer
Yang, Y. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83871 · Cited by 1,359
Doench, J. G., Petersen, C. P., & Sharp, P. A. (2003) · Genes & Development · doi:10.1101/gad.1064703 · Cited by 1,260
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons
Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., Hannon, G., & Abeliovich, A. (2007) · Science · doi:10.1126/science.1140481 · Cited by 1,187
Challenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173
Parodi, A., Quattrocchi, N., van de Ven, A. L., Chiappini, C., Evangelopoulos, M., Martinez, J. O., Brown, B. S., Khaled, S. Z., Yazdi, I. K., Enzo, M. V., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.212 · Cited by 1,168
Targeting the tumour stroma to improve cancer therapy
Valkenburg, K. C., de Groot, A. E., & Pienta, K. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0007-1 · Cited by 1,084
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Chitosan-based drug delivery systems
Bernkop-Schnürch, A., & Dünnhaupt, S. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.007 · Cited by 991
Size and shape effects in the biodistribution of intravascularly injected particles
Decuzzi, P., Godin, B., Tanaka, T., Lee, S.-Y., Chiappini, C., Liu, X., & Ferrari, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.014 · Cited by 965
Self-citationAltered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis
Stanczyk, J., Pedrioli, D. M. L., Brentano, F., Sanchez‐Pernaute, O., Kolling, C., Gay, R. E., Detmar, M., Gay, S., & Kyburz, D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23386 · Cited by 904
The Lin28/let-7 Axis Regulates Glucose Metabolism
Zhu, H., Shyh-Chang, N., Segrè, A. V., Shinoda, G., Shah, S. P., Einhorn, W. S., Takeuchi, A., Engreitz, J. M., Hagan, J. P., Kharas, M. G., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.033 · Cited by 900
Quezada, S. A., Simpson, T. R., Peggs, K. S., Merghoub, T., Vider, J., Fan, X., Blasberg, R., Yagita, H., Muranski, P., Antony, P. A., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091918 · Cited by 898
Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence
Grizzi, I., Garreau, H., Li, S., & Vert, M. (1995) · Biomaterials · doi:10.1016/0142-9612(95)93258-f · Cited by 895
Emerging issues in AAV-mediated in vivo gene therapy
Colella, P., Ronzitti, G., & Mingozzi, F. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.007 · Cited by 881
RNA interference in the clinic: challenges and future directions
Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G., & Sood, A. K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2966 · Cited by 820
Keeping It All Going—Complement Meets Metabolism
Kolev, M., & Kemper, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00001 · Cited by 812
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
Smith, T. T., Stephan, S. B., Moffett, H. F., McKnight, L. E., Ji, W., Reiman, D., Bonagofski, E., Wohlfahrt, M. E., Pillai, S. P. S., & Stephan, M. T. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.57 · Cited by 785
MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes
Jayawardena, T. M., Egemnazarov, B., Finch, E. A., Zhang, L., Payne, J. A., Pandya, K., Zhang, Z., Rosenberg, P., Mirotsou, M., & Dzau, V. J. (2012) · Circulation Research · doi:10.1161/circresaha.112.269035 · Cited by 775
Multifunctional Gold Nanoparticles for Diagnosis and Therapy of Disease
Mieszawska, A. J., Mulder, W. J. M., Fayad, Z. A., & Cormode, D. P. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005885 · Cited by 724
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
Cheng, X., & Lee, R. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.022 · Cited by 703
Wang, W.-X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., Rigoutsos, I., & Nelson, P. T. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5065-07.2008 · Cited by 701
Farazi, T. A., Hoell, J. I., Morozov, P., & Tuschl, T. (2013) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-007-5590-1_1 · Cited by 693
The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development
Visvanathan, J., Lee, S., Lee, B., Lee, J. W., & Lee, S.-K. (2007) · Genes & Development · doi:10.1101/gad.1519107 · Cited by 683
Self-citationIn vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Chen, Y., Gao, D.-Y., & Huang, L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.009 · Cited by 672
Hyaluronan: A simple polysaccharide with diverse biological functions
Dicker, K. T., Gurski, L. A., Pradhan-Bhatt, S., Witt, R. L., Farach-Carson, M. C., & Jia, X. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.12.019 · Cited by 671
Trang, P., Wiggins, J. F., Daige, C. L., Cho, C., Omotola, M., Brown, D., Weidhaas, J. B., Bader, A. G., & Slack, F. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.48 · Cited by 667
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells
Czauderna, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg393 · Cited by 623
Essandoh, K., Li, Y., Huo, J., & Fan, G.-C. (2016) · Shock · doi:10.1097/shk.0000000000000604 · Cited by 606
Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure
Montgomery, R. L., Hullinger, T. G., Semus, H. M., Dickinson, B. A., Seto, A. G., Lynch, J. M., Stack, C., Latimer, P. A., Olson, E. N., & van Rooij, E. (2011) · Circulation · doi:10.1161/circulationaha.111.030932 · Cited by 603
A Cellular Trojan Horse for Delivery of Therapeutic Nanoparticles into Tumors
Choi, M.-R., Stanton-Maxey, K. J., Stanley, J. K., Levin, C. S., Bardhan, R., Akin, D., Badve, S., Sturgis, J., Robinson, J. P., Bashir, R., et al. (2007) · Nano Letters · doi:10.1021/nl072209h · Cited by 584
Chitosan-Based Particles as Controlled Drug Delivery Systems
Prabaharan, M., & Mano, J. F. (2004) · Drug Delivery · doi:10.1080/10717540590889781 · Cited by 564
Cai, Y., Xue, F., Fleming, C., Yang, J., Ding, C., Ma, Y., Liu, M., Zhang, H.-G., Zheng, J., Xiong, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms11354 · Cited by 531
Remote control of cellular behaviour with magnetic nanoparticles
Dobson, J. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.39 · Cited by 528
Deng, X., Cao, M., Zhang, J., Hu, K., Yin, Z., Zhou, Z., Xiao, X., Yang, Y., Sheng, W., Wu, Y., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.006 · Cited by 511
PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application
Grossen, P., Witzigmann, D., Sieber, S., & Huwyler, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.028 · Cited by 496
Miñones-Moyano, E., Porta, S., Escaramís, G., Rabionet, R., Iraola, S., Kagerbauer, B., Espinosa-Parrilla, Y., Ferrer, I., Estivill, X., & Martí, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr210 · Cited by 482
Plasma miR-208 as a Biomarker of Myocardial Injury
Ji, X., Takahashi, R., Hiura, Y., Hirokawa, G., Fukushima, Y., & Iwai, N. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.125310 · Cited by 476
First microRNA mimic enters clinic
Bouchie, A. (2013) · Nature Biotechnology · doi:10.1038/nbt0713-577 · Cited by 472
Nanoparticle-Based Immunotherapy for Cancer
Shao, K., Singha, S., Clemente-Casares, X., Tsai, S., Yang, Y., & Santamaria, P. (2015) · ACS Nano · doi:10.1021/nn5062029 · Cited by 470
Dong, S., Cheng, Y., Yang, J., Li, J., Liu, X., Wang, X., Wang, D., Krall, T. J., Delphin, E. S., & Zhang, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027896 · Cited by 454
Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153
Doxakis, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.086827 · Cited by 454
Alterations of the microRNA network cause neurodegenerative disease
Hébert, S. S., & De Strooper, B. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.003 · Cited by 452
Wang, G., van der Walt, J. M., Mayhew, G., Li, Y.-J., Züchner, S., Scott, W. K., Martin, E. R., & Vance, J. M. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.09.021 · Cited by 440
Chemical modification and design of anti-miRNA oligonucleotides
Lennox, K. A., & Behlke, M. A. (2011) · Gene Therapy · doi:10.1038/gt.2011.100 · Cited by 433
Role of microRNAs in translation regulation and cancer
Oliveto, S., Mancino, M., Manfrini, N., & Biffo, S. (2017) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v8.i1.45 · Cited by 431
Polymer systems for gene delivery—Past, present, and future
Wong, S. Y., Pelet, J. M., & Putnam, D. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.007 · Cited by 427
Chen, D., Love, K. T., Chen, Y., Eltoukhy, A. A., Kastrup, C., Sahay, G., Jeon, A., Dong, Y., Whitehead, K. A., & Anderson, D. G. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301621z · Cited by 424
Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles
Arvizo, R. R., Miranda, O. R., Moyano, D. F., Walden, C. A., Giri, K., Bhattacharya, R., Robertson, J. D., Rotello, V. M., Reid, J. M., & Mukherjee, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024374 · Cited by 403
MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
Ibrahim, A. F., Weirauch, U., Thomas, M., Grünweller, A., Hartmann, R. K., & Aigner, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4645 · Cited by 400
Absolute and Direct MicroRNA Quantification Using DNA–Gold Nanoparticle Probes
Degliangeli, F., Kshirsagar, P., Brunetti, V., Pompa, P. P., & Fiammengo, R. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412152x · Cited by 385
Stimuli-responsive nanoparticles for targeting the tumor microenvironment
Du, J., Lane, L. A., & Nie, S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.050 · Cited by 382
A Cardiac MicroRNA Governs Systemic Energy Homeostasis by Regulation of MED13
Grueter, C. E., van Rooij, E., Johnson, B. A., DeLeon, S. M., Sutherland, L. B., Qi, X., Gautron, L., Elmquist, J. K., Bassel-Duby, R., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.03.029 · Cited by 364
Ganesh, S., Iyer, A. K., Morrissey, D. V., & Amiji, M. M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.077 · Cited by 362
MicroRNA-125b Potentiates Macrophage Activation
Chaudhuri, A. A., So, A. Y.-L., Sinha, N., Gibson, W. S. J., Taganov, K. D., O’Connell, R. M., & Baltimore, D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102001 · Cited by 327
A different vision of dyslexia: Local precedence on global perception
Franceschini, S., Bertoni, S., Gianesini, T., Gori, S., & Facoetti, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-17626-1 · Cited by 317
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis
Emerich, D. F., & Thanos, C. G. (2006) · Biomolecular Engineering · doi:10.1016/j.bioeng.2006.05.026 · Cited by 312
Martinez-Nunez, R. T., Louafi, F., & Sanchez-Elsner, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169367 · Cited by 308
Griset, A. P., Walpole, J., Liu, R., Gaffey, A., Colson, Y. L., & Grinstaff, M. W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja807416t · Cited by 305
Boissonneault, V., Plante, I., Rivest, S., & Provost, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807530200 · Cited by 301
MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment
Quiat, D., & Olson, E. N. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62876 · Cited by 300
Bioorthogonal Copper‐Free Click Chemistry In Vivo for Tumor‐Targeted Delivery of Nanoparticles
Koo, H., Lee, S., Na, J. H., Kim, S. H., Hahn, S. K., Choi, K., Kwon, I. C., Jeong, S. Y., & Kim, K. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201206703 · Cited by 293
Self-citationDelivering the promise of miRNA cancer therapeutics
Pereira, D. M., Rodrigues, P. M., Borralho, P. M., & Rodrigues, C. M. P. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.10.002 · Cited by 288
Detecting microRNA binding and siRNA off-target effects from expression data
van Dongen, S., Abreu-Goodger, C., & Enright, A. J. (2008) · Nature Methods · doi:10.1038/nmeth.1267 · Cited by 273
In vitro biocompatibility assessment of poly(ε-caprolactone) films using L929 mouse fibroblasts
Serrano, M. C., Pagani, R., Vallet-Regı́, M., Peña, J., Rámila, A., Izquierdo, I., & Portolés, M. T. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.01.037 · Cited by 273
Polymeric nanoparticles for siRNA delivery and gene silencing
Patil, Y., & Panyam, J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.039 · Cited by 270
van Solingen, C., Seghers, L., Bijkerk, R., Duijs, J. M. G. J., Roeten, M. K., van Oeveren‐Rietdijk, A. M., Baelde, H. J., Monge, M., Vos, J. B., de Boer, H. C., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00613.x · Cited by 269
Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects
Zhang, X., Li, Y., Chen, Y. E., Chen, J., & Ma, P. X. (2016) · Nature Communications · doi:10.1038/ncomms10376 · Cited by 268
Chitosan and Its Derivatives for Drug Delivery Perspective
Sonia, T. A., & Sharma, C. P. (2011) · Advances in Polymer Science · doi:10.1007/12_2011_117 · Cited by 266
Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System
Barbero, F., Russo, L., Vitali, M., Piella, J., Salvo, I., Borrajo, M. L., Busquets-Fité, M., Grandori, R., Bastús, N. G., Casals, E., et al. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.10.001 · Cited by 263
Zhu, G., Mei, L., Vishwasrao, H. D., Jacobson, O., Wang, Z., Liu, Y., Yung, B. C., Fu, X., Jin, A., Niu, G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01386-7 · Cited by 255
Geekiyanage, H., & Chan, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3883-11.2011 · Cited by 254
Murphy, A. J., Guyre, P. M., & Pioli, P. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903463 · Cited by 250
Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease
Martins, M., Rosa, A., Guedes, L. C., Fonseca, B. V., Gotovac, K., Violante, S., Mestre, T., Coelho, M., Rosa, M. M., Martin, E. R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025443 · Cited by 245
Li, D., Liu, X., Lin, L., Hou, J., Li, N., Wang, C., Wang, P., Zhang, Q., Zhang, P., Zhou, W., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.270561 · Cited by 245
Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
Saadatpour, L., Fadaee, E., Fadaei, S., Nassiri Mansour, R., Mohammadi, M., Mousavi, S. M., Goodarzi, M., Verdi, J., & Mirzaei, H. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.48 · Cited by 244
Advances in chitosan-based drug delivery vehicles
Hu, L., Sun, Y., & Wu, Y. (2013) · Nanoscale · doi:10.1039/c3nr00338h · Cited by 243
Yang, Y.-P., Chien, Y., Chiou, G.-Y., Cherng, J.-Y., Wang, M.-L., Lo, W.-L., Chang, Y.-L., Huang, P.-I., Chen, Y.-W., Shih, Y.-H., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.071 · Cited by 240
Wang, L. L., Liu, Y., Chung, J. J., Wang, T., Gaffey, A. C., Lu, M., Cavanaugh, C. A., Zhou, S., Kanade, R., Atluri, P., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0157-y · Cited by 239
Cun, D., Jensen, D. K., Maltesen, M. J., Bunker, M., Whiteside, P., Scurr, D., Foged, C., & Nielsen, H. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.008 · Cited by 233
Tivnan, A., Orr, W. S., Gubala, V., Nooney, R., Williams, D. E., McDonagh, C., Prenter, S., Harvey, H., Domingo-Fernández, R., Bray, I. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038129 · Cited by 233
Bejerano, T., Etzion, S., Elyagon, S., Etzion, Y., & Cohen, S. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b02578 · Cited by 230
Targeting immune cells for cancer therapy
Gun, S. Y., Lee, S. W. L., Sieow, J. L., & Wong, S. C. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101174 · Cited by 229
Self-citationRestoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation
Li, S.-Y., Liu, Y., Xu, C.-F., Shen, S., Sun, R., Du, X.-J., Xia, J.-X., Zhu, Y.-H., & Wang, J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.044 · Cited by 222
miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma
Kouri, F. M., Hurley, L. A., Daniel, W. L., Day, E. S., Hua, Y., Hao, L., Peng, C.-Y., Merkel, T. J., Queisser, M. A., Ritner, C., et al. (2015) · Genes & Development · doi:10.1101/gad.257394.114 · Cited by 220
Current issues of RNAi therapeutics delivery and development
Haussecker, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.056 · Cited by 217
Nanoparticles Escaping RES and Endosome: Challenges for siRNA Delivery for Cancer Therapy
Guo, S., & Huang, L. (2011) · Journal of Nanomaterials · doi:10.1155/2011/742895 · Cited by 216
MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1
Zhu, H.-C., Wang, L.-M., Wang, M., Song, B., Tan, S., Teng, J.-F., & Duan, D.-X. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.05.018 · Cited by 204
Polyethylenimines for siRNA and miRNA delivery in vivo
Höbel, S., & Aigner, A. (2013) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1228 · Cited by 201
Transfection of microRNA Mimics Should Be Used with Caution
Jin, H. Y., Gonzalez-Martin, A., Miletic, A. V., Lai, M., Knight, S., Sabouri-Ghomi, M., Head, S. R., Macauley, M. S., Rickert, R. C., & Xiao, C. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00340 · Cited by 192
Cell‐Based Drug Delivery Devices Using Phagocytosis‐Resistant Backpacks
Doshi, N., Swiston, A. J., Gilbert, J. B., Alcaraz, M. L., Cohen, R. E., Rubner, M. F., & Mitragotri, S. (2011) · Advanced Materials · doi:10.1002/adma.201004074 · Cited by 191
Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier
Chae, S. Y., Son, S., Lee, M., Jang, M.-K., & Nah, J.-W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.040 · Cited by 188
Song, Y., Tang, C., & Yin, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.017 · Cited by 188
Costa, P. M., Cardoso, A. L., Custódia, C., Cunha, P., Pereira de Almeida, L., & Pedroso de Lima, M. C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.002 · Cited by 187
Wang, S., Zhang, J., Wang, Y., & Chen, M. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.014 · Cited by 186
Lamprecht, A., Ubrich, N., Hombreiro Pérez, M., Lehr, C.-M., Hoffman, M., & Maincent, P. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00422-6 · Cited by 185
Cohen, Z. R., Ramishetti, S., Peshes-Yaloz, N., Goldsmith, M., Wohl, A., Zibly, Z., & Peer, D. (2015) · ACS Nano · doi:10.1021/nn506248s · Cited by 182
Lipid Nanoparticles for Gene Delivery
Zhao, Y., & Huang, L. (2014) · Advances in Genetics · doi:10.1016/b978-0-12-800148-6.00002-x · Cited by 178
miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNS
Wang, H., Moyano, A. L., Ma, Z., Deng, Y., Lin, Y., Zhao, C., Zhang, L., Jiang, M., He, X., Ma, Z., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.03.001 · Cited by 174 · cited 1×
“CNS, regulating oligodendrocyte differentiation and myelination [235].”
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
Hsu, S.-H., Yu, B., Wang, X., Lu, Y., Schmidt, C. R., Lee, R. J., Lee, L. J., Jacob, S. T., & Ghoshal, K. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.05.007 · Cited by 173
A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells
Ghosh, R., Singh, L. C., Shohet, J. M., & Gunaratne, P. H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.023 · Cited by 172
Non-coding RNAs in Alzheimer's Disease
Tan, L., Yu, J.-T., Hu, N., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8359-5 · Cited by 171
Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2
Miyazaki, Y., Adachi, H., Katsuno, M., Minamiyama, M., Jiang, Y., Huang, Z., Doi, H., Matsumoto, S., Kondo, N., Iida, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2791 · Cited by 169
Siriwon, N., Kim, Y. J., Siegler, E., Chen, X., Rohrs, J. A., Liu, Y., & Wang, P. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0502 · Cited by 169
Hébert, S. S., & De Strooper, B. (2007) · Science · doi:10.1126/science.1148530 · Cited by 163
MiR-146a modulates macrophage polarization by inhibiting Notch1 pathway in RAW264.7 macrophages
Huang, C., Liu, X.-J., QunZhou, Xie, J., Ma, T.-T., Meng, X.-M., & Li, J. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.009 · Cited by 160
Anselmo, A. C., Gilbert, J. B., Kumar, S., Gupta, V., Cohen, R. E., Rubner, M. F., & Mitragotri, S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.027 · Cited by 159
Targeted Delivery Systems for Oligonucleotide Therapeutics
Yu, B., Zhao, X., Lee, L. J., & Lee, R. J. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9096-1 · Cited by 158
Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
Cosco, D., Cilurzo, F., Maiuolo, J., Federico, C., Martino, M. T. D., Cristiano, M. C., Tassone, P., Fresta, M., & Paolino, D. (2015) · Scientific Reports · doi:10.1038/srep17579 · Cited by 155
Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse
Choi, M.-R., Bardhan, R., Stanton-Maxey, K. J., Badve, S., Nakshatri, H., Stantz, K. M., Cao, N., Halas, N. J., & Clare, S. E. (2012) · Cancer Nanotechnology · doi:10.1007/s12645-012-0029-9 · Cited by 154
Cationic Polymer Optimization for Efficient Gene Delivery
Sun, X., & Zhang, N. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955710791185109 · Cited by 152
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
Lee, T. J., Yoo, J. Y., Shu, D., Li, H., Zhang, J., Yu, J.-G., Jaime‐Ramirez, A. C., Acunzo, M., Romano, G., Cui, R., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.016 · Cited by 151
Josep Sardanyés, A., Simó, C., Martínez, R., Solé, R. V., & Elena, S. F. (2015) · Scientific Reports · doi:10.1038/srep11167 · Cited by 151
Bertucci, A., Prasetyanto, E. A., Septiadi, D., Manicardi, A., Brognara, E., Gambari, R., Corradini, R., & Cola, L. D. (2015) · Small · doi:10.1002/smll.201500540 · Cited by 150
MicroRNA: Dynamic Regulators of Macrophage Polarization and Plasticity
Self-Fordham, J., Naqvi, A. R., Uttamani, J. R., Kulkarni, V., & Nares, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01062 · Cited by 148
Chiou, G., Cherng, J., Hsu, H., Wang, M., Tsai, C., Lu, K., Chien, Y., Hung, S., Chen, Y., Wong, C.-I., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.014 · Cited by 146
Silva, J. M., Zupančič, E., Vandermeulen, G., Oliveira, V. G., Salgado, A., Videira, M., Gaspar, M. M., Graça, L., Véronique Préat, A., & Florindo, H. F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.033 · Cited by 146
Molecular Dynamics Simulations of DNA/PEI Complexes: Effect of PEI Branching and Protonation State
Sun, C., Tang, T., Uludağ, H., & Cuervo, J. E. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.04.045 · Cited by 145
Chen, X., Gu, S., Chen, B., Shen, W., Yin, Z., Xu, G., Hu, J., Zhu, T., Li, G., Wan, C., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.071 · Cited by 142
PTEN ceRNA networks in human cancer
Poliseno, L., & Pandolfi, P. P. (2015) · Methods · doi:10.1016/j.ymeth.2015.01.013 · Cited by 141
MicroRNAs regulate osteogenesis and chondrogenesis.
Dong, S.-W., Yang, B., Guo, H., & Kang, F. (2012) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2012.01.075 · Cited by 137
MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy
Smith, P. Y., Delay, C., Girard, J., Papon, M.-A., Planel, E., Sergeant, N., Buée, L., & Hébert, S. S. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr330 · Cited by 136
Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function
Delay, C., Calon, F., Mathews, P. M., & Hébert, S. S. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-70 · Cited by 135
Yin, P. T., Shah, B. P., & Lee, K. (2014) · Small · doi:10.1002/smll.201400963 · Cited by 135
Kim, S. H., Mok, H., Jeong, J. H., Kim, S. W., & Park, T. G. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050289f · Cited by 129
Lee, M. S., Lee, J. E., Byun, E., Kim, N. W., Lee, K., Lee, H., Sim, S. J., Lee, D. S., & Jeong, J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.049 · Cited by 129
miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy
Karnati, H. K., Panigrahi, M. K., Gutti, R. K., Greig, N. H., & Tamargo, I. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150395 · Cited by 128
Maintaining the silence: reflections on long-term RNAi
Raemdonck, K., Vandenbroucke, R. E., Demeester, J., Sanders, N. N., & Smedt, S. C. D. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.06.008 · Cited by 124
Liu, Q., Li, R., Qian, H., Wei, J., Li, X., Shen, J., Yang, M., Qian, X., Yu, L., Jiang, X., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.004 · Cited by 123
On Measuring miRNAs after Transient Transfection of Mimics or Antisense Inhibitors
Thomson, D. W., Bracken, C. P., Szubert, J. M., & Goodall, G. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055214 · Cited by 122
Santos-Carballal, B., Aaldering, L. J., Ritzefeld, M., Pereira, S., Sewald, N., Moerschbacher, B. M., Götte, M., & Goycoolea, F. M. (2015) · Scientific Reports · doi:10.1038/srep13567 · Cited by 121
A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells
Warashina, S., Nakamura, T., Sato, Y., Fujiwara, Y., Hyodo, M., Hatakeyama, H., & Harashima, H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.042 · Cited by 120
Dante, S., Petrelli, A., Petrini, E. M., Marotta, R., Maccione, A., Alabastri, A., Quarta, A., Donato, F. D., Ravasenga, T., Sathya, A., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b00397 · Cited by 119
Ahmadi, A. A., Leipsic, J. A., Feuchtner, G. M., Gransar, H., Kalra, D. K., Heo, R., Achenbach, S. S., Andreini, D., Al-Mallah, M. H., Berman, D. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118998 · Cited by 116
Gan, Y., Yao, W., Xiao, W., Li, H., Xu, H., & Lang, B. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0115-4 · Cited by 113
Formation of a protein corona influences the biological identity of nanomaterials
Nierenberg, D., Khaled, A. R., & Flores, O. (2018) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2018.05.005 · Cited by 111
Polyalkylcyanoacrylates as colloidal drug carriers.
Couvreur, P. (1988) · PubMed · Cited by 110
Louw, A. M., Kolar, M. K., Novikova, L. N., Kingham, P. J., Wiberg, M., Kjems, J., & Novikov, L. N. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.10.011 · Cited by 109
Bioinspired Negatively Charged Calcium Phosphate Nanocarriers for Cardiac Delivery of MicroRNAs
Mauro, V. D., Iafisco, M., Salvarani, N., Vacchiano, M., Carullo, P., Ramírez‐Rodríguez, G. B., Patrício, T., Tampieri, A., Miragoli, M., & Catalucci, D. (2016) · Nanomedicine · doi:10.2217/nnm.16.26 · Cited by 107
Gray, G. D., Basu, S., & Wickstrom, E. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)82440-9 · Cited by 105
Enabling Cytoplasmic Delivery and Organelle Targeting by Surface Modification of Nanocarriers
Parodi, A., Corbo, C., Cevenini, A., Molinaro, R., Palomba, R., Pandolfi, L., Agostini, M., Salvatore, F., & Tasciotti, E. (2015) · Nanomedicine · doi:10.2217/nnm.15.39 · Cited by 102
Circulating MicroRNAs: Potential Biomarkers for Cancer
Yu, D., Li, Q., Ding, X., & Ding, Y.-T. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12032055 · Cited by 100
Nanoparticle-Based Modulation of the Immune System
Fang, R. H., & Zhang, L. (2016) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-080615-034446 · Cited by 100
Ekin, A., Karataş, Ö. F., Çulha, M., & Özen, M. (2014) · The Journal of Gene Medicine · doi:10.1002/jgm.2810 · Cited by 99
MicroRNA-Related Cofilin Abnormality in Alzheimer's Disease
Yao, J., Hennessey, T., Flynt, A. S., Lai, E. C., Beal, M. F., & Lin, M. T. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015546 · Cited by 99
Noncoding RNAs in gene regulation
Wéry, M., Kwapisz, M., & Morillon, A. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.148 · Cited by 93
Mohamed, A. A., Kunda, N. K., Ross, K., Hutcheon, G. A., & Saleem, I. Y. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.01.002 · Cited by 93
Sekhon, B. S., & Kamboj, S. R. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.04.003 · Cited by 92
Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid
Layek, B., Lipp, L., & Singh, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226142 · Cited by 91
Anti-inflammatory effects of miR-21 in the macrophage response to peritonitis
Barnett, R. E., Conklin, D. J., Ryan, L. E., Keskey, R. C., Ramjee, V., Sepulveda, E. A., Srivastava, S., Bhatnagar, A., & Cheadle, W. G. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a1014-489r · Cited by 90
Xie, Y., Stewart, T. M., Wang, Y., Yu, F., Li, J., Marton, L. J., Casero, R. A., & Oupický, D. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.017 · Cited by 90
Design, preparation and application of nucleic acid delivery carriers
Yang, J., Liu, H., & Zhang, X. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.11.004 · Cited by 89
Cha, W., Fan, R., Miao, Y., Zhou, Y., Qin, C., Shan, X., Wan, X., & Li, J. (2017) · Molecules · doi:10.3390/molecules22050782 · Cited by 85
Bravo‐Anaya, L. M., Fernández‐Solís, K. G., Rosselgong, J., Rodríguez, J. L. E. N., Carvajal, F., & Rinaudo, M. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.008 · Cited by 83
Caracciolo, G., Caputo, D. D., Pozzi, D., Colapicchioni, V., & Coppola, R. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.10.008 · Cited by 82
Preparation of a Low Molecular Weight Polyethylenimine for Efficient Cell Transfection
Bieber, T., & Elsässer, H. (2001) · BioTechniques · doi:10.2144/01301st03 · Cited by 80
A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA
Zhang, T., Xue, X., He, D., & Hsieh, J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.003 · Cited by 80
Renal uptake of an 18-mer phosphorothioate oligonucleotide
Oberbauer, R. W., Schreiner, G. F., & Meyer, T. W. (1995) · Kidney International · doi:10.1038/ki.1995.406 · Cited by 76
Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles
Schade, A., Delyagina, E., Scharfenberg, D., Skorska, A., Lux, C. A., David, R., & Steinhoff, G. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140610710 · Cited by 76
Micro RNA -214,-150,-146a and-125b target Huntingtin gene
Sinha, M., Ghose, J., & Bhattarcharyya, N. P. (2011) · RNA Biology · doi:10.4161/rna.8.6.16035 · Cited by 75
Yuan, X., Shah, B. A., Kotadia, N. K., Li, J., Gu, H., & Wu, Z. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0103-0 · Cited by 73
Liang, G., Zhu, Y., Jing, A., Wang, J., Hu, F., Feng, W., Xiao, Z., & Chen, B. (2016) · Gene Therapy · doi:10.1038/gt.2016.60 · Cited by 73
Conde, J., Edelman, E. R., & Artzi, N. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.003 · Cited by 72
Bilen, J., Liu, N., & Bonini, N. M. (2006) · Cell Cycle · doi:10.4161/cc.5.24.3579 · Cited by 72
Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone
Kwon, E. J., Lasiene, J., Jacobson, B. E., Park, I., Horner, P. J., & Pun, S. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.086 · Cited by 72
T lymphocytes as potential therapeutic drug carrier for cancer treatment
Steinfeld, U., Pauli, C., Kaltz, N., Bergemann, C., & Lee, H.-H. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.12.040 · Cited by 70
Bhargava-Shah, A., Foygel, K., Devulapally, R., & Paulmurugan, R. (2016) · Nanomedicine · doi:10.2217/nnm.15.193 · Cited by 70
Yang, J., Brown, M. E., Zhang, H., Martinez, M. D., Zhao, Z., Bhutani, S., Yin, S., Trac, D. Q., Xi, J., & Davis, M. E. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00685.2016 · Cited by 70
Cited by
RNAi-based therapeutics and tumor targeted delivery in cancer
Kara, G., Calin, G. A., & Ozpolat, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114113 · Cited by 411
Liang, Y., Xu, X., Li, X., Xiong, J., Li, B., Duan, L., Wang, D., & Xia, J. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c10458 · Cited by 391
Ouyang, Q., Liu, K., Zhu, Q., Deng, H., Le, Y., Ouyang, W., Yan, X., Zhou, W., & Tong, J. (2022) · Small · doi:10.1002/smll.202107534 · Cited by 94
Gajos-Michniewicz, A., & Czyz, M. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2023.02.050 · Cited by 89
Xia, W., Li, M., Jiang, X., Huang, X., Gu, S., Ye, J., Zhu, L., Hou, M., & Zan, T. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01348-2 · Cited by 72
Metadata
- Authors
- Lee, S. W. L., Paoletti, C., Campisi, M., Osaki, T., Adriani, G., Kamm, R. D., Mattu, C., & Chiono, V.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 313
- Pages
- 80-95
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2980389467
- Cited by
- 437
- References
- 244
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.